Your browser doesn't support javascript.
loading
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.
Oehler, Vivian G; Guthrie, Katherine A; Cummings, Carrie L; Sabo, Kathleen; Wood, Brent L; Gooley, Ted; Yang, Taimei; Epping, Mirjam T; Shou, Yaping; Pogosova-Agadjanyan, Era; Ladne, Paula; Stirewalt, Derek L; Abkowitz, Janis L; Radich, Jerald P.
Affiliation
  • Oehler VG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. voehler@u.washington.edu
Blood ; 114(15): 3299-308, 2009 Oct 08.
Article in En | MEDLINE | ID: mdl-19625708
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Hematopoietic Stem Cells / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gene Expression Regulation, Leukemic / Cell Differentiation / Granulocytes / Antigens, Neoplasm Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Blood Year: 2009 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Hematopoietic Stem Cells / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gene Expression Regulation, Leukemic / Cell Differentiation / Granulocytes / Antigens, Neoplasm Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Blood Year: 2009 Type: Article Affiliation country: United States